A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Stryker Corp stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 130,750 shares of SYK stock, worth $48.5 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
130,750
Previous 67,412 93.96%
Holding current value
$48.5 Million
Previous $22.9 Million 105.91%
% of portfolio
0.25%
Previous 0.13%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$315.94 - $371.96 $20 Million - $23.6 Million
63,338 Added 93.96%
130,750 $47.2 Million
Q2 2024

Aug 14, 2024

BUY
$324.3 - $354.67 $5.81 Million - $6.35 Million
17,918 Added 36.2%
67,412 $22.9 Million
Q1 2024

May 15, 2024

BUY
$293.94 - $358.71 $14.5 Million - $17.8 Million
49,494 New
49,494 $17.5 Billion
Q4 2023

Aug 14, 2024

BUY
$253.85 - $299.46 $1.31 Million - $1.54 Million
5,141 Added 12.45%
46,435 $13.9 Billion
Q3 2023

Aug 14, 2024

SELL
$266.54 - $302.43 $53,308 - $60,486
-200 Reduced 0.48%
41,294 $11.3 Billion
Q2 2023

Aug 14, 2024

BUY
$271.49 - $305.09 $5.21 Million - $5.86 Million
19,205 Added 86.16%
41,494 $12.7 Billion
Q1 2023

Aug 14, 2024

SELL
$246.13 - $285.47 $2.98 Million - $3.45 Million
-12,092 Reduced 35.17%
22,289 $6.36 Billion
Q4 2022

Aug 14, 2024

BUY
$205.51 - $253.93 $189,274 - $233,869
921 Added 2.75%
34,381 $8.41 Billion
Q3 2022

Aug 14, 2024

BUY
$189.27 - $231.83 $55,266 - $67,694
292 Added 0.88%
33,460 $6.78 Billion
Q2 2022

Aug 14, 2024

BUY
$194.09 - $276.37 $228,832 - $325,840
1,179 Added 3.69%
33,168 $6.6 Billion
Q1 2022

Aug 14, 2024

SELL
$245.33 - $277.77 $8.69 Million - $9.84 Million
-35,423 Reduced 52.55%
31,989 $8.55 Billion
Q4 2021

Aug 30, 2024

BUY
$236.63 - $276.44 $274,727 - $320,946
1,161 Added 2.85%
41,863 $11.2 Billion
Q3 2021

Aug 30, 2024

BUY
$248.9 - $280.09 $103,542 - $116,517
416 Added 1.03%
40,702 $10.7 Billion
Q2 2021

Aug 30, 2024

SELL
$242.95 - $267.0 $6.59 Million - $7.24 Million
-27,126 Reduced 40.24%
40,286 $10.5 Billion
Q1 2021

Aug 30, 2024

SELL
$221.01 - $248.82 $138,794 - $156,258
-628 Reduced 1.59%
38,899 $9.48 Billion
Q4 2020

Aug 30, 2024

BUY
$202.01 - $245.04 $2,424 - $2,940
12 Added 0.03%
39,527 $9.69 Billion
Q3 2020

Aug 30, 2024

BUY
$177.77 - $215.81 $332,074 - $403,133
1,868 Added 4.96%
39,515 $8.23 Billion
Q2 2020

Aug 30, 2024

SELL
$144.67 - $207.03 $7.72 Million - $11.1 Million
-53,382 Reduced 58.64%
37,647 $6.78 Billion
Q1 2020

Aug 30, 2024

BUY
$126.5 - $225.1 $6.21 Million - $11 Million
49,068 Added 116.94%
91,029 $15.2 Billion
Q4 2019

Aug 30, 2024

SELL
$197.98 - $220.53 $13.2 Million - $14.7 Million
-66,755 Reduced 61.4%
41,961 $8.81 Billion
Q3 2019

Aug 30, 2024

BUY
$205.4 - $221.82 $91,403 - $98,709
445 Added 0.41%
108,716 $23.5 Billion
Q2 2019

Aug 30, 2024

BUY
$180.24 - $205.58 $1.63 Million - $1.86 Million
9,058 Added 9.13%
108,271 $22.3 Billion
Q1 2019

Aug 30, 2024

BUY
$152.46 - $198.0 $457 - $594
3 Added 0.0%
99,213 $19.6 Billion
Q4 2018

Aug 30, 2024

BUY
$145.0 - $178.65 $4.61 Million - $5.68 Million
31,798 Added 47.17%
99,210 $15.6 Billion
Q3 2018

Aug 30, 2024

SELL
$163.25 - $177.68 $3.49 Million - $3.8 Million
-21,402 Reduced 18.05%
97,199 $17.3 Billion
Q2 2018

Aug 30, 2024

BUY
$155.17 - $179.78 $293,891 - $340,503
1,894 Added 1.62%
118,601 $20 Billion
Q1 2018

Aug 30, 2024

BUY
$148.01 - $168.91 $660,716 - $754,014
4,464 Added 3.98%
116,707 $18.8 Billion
Q4 2017

Aug 30, 2024

BUY
$143.51 - $159.74 $463,537 - $515,960
3,230 Added 2.96%
112,243 $17.4 Billion
Q3 2017

Aug 30, 2024

SELL
$138.36 - $147.87 $388,929 - $415,662
-2,811 Reduced 2.51%
109,013 $15.5 Billion
Q2 2017

Aug 30, 2024

BUY
N/A
28,010 Added 33.42%
111,824 $15.5 Billion
Q1 2017

Aug 30, 2024

BUY
N/A
16,402
83,814 $11 Billion

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $140B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.